https://doi.org/10.4081/monaldi.2018.954
Prognostic impact of digoxin use for rate control of atrial fibrillation in patients ≥75 years of age
Accepted: May 11, 2018
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Digoxin use remains a common therapeutic option in the pharmacological control of heart rate in patients with atrial fibrillation, endorsed in current guidelines with the same level of evidence than beta-blockers in patients with and without heart failure. Digoxin has a narrow therapeutic range and is influenced by drugâ€toâ€drug interactions, serum electrolyte concentrations, and renal function. Conflicting data exist regarding adverse outcomes that are associated with digoxin use in patients with atrial fibrillation. It remains unclear whether the association between digoxin use and worse clinical outcome is causal or may be the result of confounding by differences in the characteristics of patents including age, comorbidities and treatment. Particularly in older patients with atrial fibrillation, who are frequently prescribed a multitude of agents for stroke prevention, treatment of cardiovascular disease and other comorbidities, use of digoxin should be cautious and instituted with assessment of drug concentrations.
How to Cite
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Leonor Mendonça Almeida, Maria Jacob, Mafalda van Zeller, Tiago Pinto, Miguel Gonçalves, Marta Drummond, Non-invasive ventilation in the elderly – never too late! , Monaldi Archives for Chest Disease: Vol. 91 No. 3 (2021)
- Shikha Jain, Puneet Khanna, Soumya Sarkar, Comparative evaluation of ventilator-associated pneumonia in critically ill COVID- 19 and patients infected with other corona viruses: a systematic review and meta-analysis , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
- Richa Tyagi, Surya Kant, Sanjeev Kumar Verma, Ram Awadh Singh Kushwaha, Santosh Kumar, Rajiv Garg, Ajay Kumar Verma, Anand Srivastava, Darshan Kumar Bajaj, Anupam Wakhlu, Anit Parihar, Akshyaya Pradhan, Riddhi Jaiswal, Spectrum of interstitial lung diseases and their association with pulmonary hypertension , Monaldi Archives for Chest Disease: Vol. 92 No. 3 (2022)
- Olga Vriz, Hani AlSergani, Ahmed Nahid Elshaer, Abdullah Shaik, Ali Hassan Mushtaq, Michele Lioncino, Bandar Alamro, Emanuele Monda, Martina Caiazza, Ciro Mauro, Eduardo Bossone, Zuhair N. Al-Hassnan, Dimpna Albert-Brotons, Giuseppe Limongelli, A complex unit for a complex disease: the HCM-Family Unit , Monaldi Archives for Chest Disease: Vol. 92 No. 3 (2022)
- Kamal Kant Sahu, Ajay Kumar Mishra, Kevin Martin, Iryna Chastain, COVID-19 and restrictive lung disease: A deadly combo to trip off the fine balance , Monaldi Archives for Chest Disease: Vol. 90 No. 2 (2020)
- Shweta Anand, Anshul Jain, Dipti Gothi, Sameer Vaidya, Rambabu Sah, Prevalence, risk factors and effects of restless legs syndrome in COPD patients , Monaldi Archives for Chest Disease: Vol. 93 No. 1 (2023)
- Berardo Sarubbi, Gabriella Farina, Diego Colonna, Anna Correra, Emanuele Romeo, Giovanni Domenico Ciriello, Guido Oppido, Maria Giovanna Russo, Subcutaneous finger cardioverter-defibrillator in low weight paediatric patients: a case series , Monaldi Archives for Chest Disease: Vol. 93 No. 1 (2023)
- Matilde Boccia, Luigi Aronne, Benito Celia, Grazia Mazzeo, Maria Ceparano, Vito D'Agnano, Roberto Parrella, Tullio Valente, Andrea Bianco, Fabio Perrotta, COVID-19 and coagulative axis: review of emerging aspects in a novel disease , Monaldi Archives for Chest Disease: Vol. 90 No. 2 (2020)
- Syed Muhammad Zubair, Muhammad Waleed Chaudhry, Ali Bin Sarwar Zubairi, Talha Shahzad, Aqusa Zahid, Ibrahim Ali Khan, Javaid Ahmed Khan, Muhammad Irfan, The effect of ivermectin on non-severe and severe COVID-19 disease and gender-based difference of its effectiveness , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Ankita Mandal, Ajay Kumar Verma, Sujit Kumar Kar, Jyoti Bajpai, Surya Kant, Santosh Kumar, Ram Avadh Singh Kushwaha, Rajiv Garg, Anand Srivastava, Darshan Kumar Bajaj, Sanjeev Kumar Verma, Shyam Chand Chaudhary, A cross-sectional study to determine the psychological distress among pulmonary tuberculosis patients during COVID-19 pandemic , Monaldi Archives for Chest Disease: Vol. 93 No. 1 (2023)
<< < 42 43 44 45 46 47 48 49 50 51 > >>
You may also start an advanced similarity search for this article.
